Recombinant Human VEGF 189 (aa 27-215) Protein | R&D Systems 8147-VE-025 product information

product summary

company name :

R&D Systems

product type :

protein

product name :

Recombinant Human VEGF 189 (aa 27-215) Protein

catalog :

8147-VE-025

quantity :

25 ug

price :

408 USD

more info or order :

R&D Systems product webpage

citations: 2

Reference
Ma S, Mangala L, Hu W, Bayaktar E, Yokoi A, Hu W, et al. CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance. Cell Rep. 2021;36:109549 pubmed publisher
Jahangiri A, Nguyen A, Chandra A, Sidorov M, Yagnik G, Rick J, et al. Cross-activating c-Met/?1 integrin complex drives metastasis and invasive resistance in cancer. Proc Natl Acad Sci U S A. 2017;114:E8685-E8694 pubmed publisher

product information

brand :

R&D Systems, a Bio-Techne Brand

catalog number base :

8147-VE

SKU :

8147-VE-025

product name :

Recombinant Human VEGF 189 (aa 27-215) Protein

Description :

The Recombinant Human VEGF 189 (aa 27-215) Protein from R&D Systems is derived from CHO. The Recombinant Human VEGF 189 (aa 27-215) Protein has been validated for the following applications: Bioactivity.

target :

VEGF

category :

Proteins and Enzymes

unit size :

25 ug

buffer :

Lyophilized from a 0.2 µm filtered solution in HCl with BSA as a carrier protein.

conjugate :

Unconjugated

purity :

>95%, by SDS-PAGE with silver staining.

species :

Human

observed molecular weight :

22-30 kDa, reducing conditions

theoretical molecular weight :

22 kDa (monomer)

gene symbol :

VEGFA

details of functionality :

Measured in a cell proliferation assay using HUVEC human umbilical vein endothelial cells. The ED50 for this effect is 4-40 ng/mL.

endotoxin note :

<0.10 EU per 1 µg of the protein by the LAL method.

accessionNumbers :

AAA36804

applications :

Bioactivity

source :

CHO-derived Recombinant Human VEGF 189 (aa 27-215) Protein

USD :

408 USD

alt names :

MVCD1, VAS, vascular endothelial growth factor A, Vascular permeability factor, Vasculotropin, VEGFA, VEGF-A, VEGFMGC70609, VPF, VPFvascular endothelial growth factor

storage :

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

more info or order :

R&D Systems product webpage